Clinical Trial Detail

NCT ID NCT02670044
Title A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

acute myeloid leukemia

Therapies

Idasanutlin + Venetoclax

Cobimetinib + Venetoclax

Age Groups: senior

No variant requirements are available.